Routine fecal occult blood testing does not predict necrotizing enterocolitis in very low birth weight neonates.

Area of Science:

• Neonatalogy
• Gastroenterology
• Diagnostic Accuracy

Background:

• Necrotizing enterocolitis (NEC) is a critical gastrointestinal emergency in premature infants.
• Early and accurate diagnosis of NEC is crucial for timely intervention and improved outcomes.
• Fecal occult blood (FOB) testing is a non-invasive method sometimes considered for gastrointestinal bleeding detection.

Purpose of the Study:

• To evaluate the diagnostic performance of routine fecal occult blood (FOB) testing.
• To determine the sensitivity, specificity, and predictive value of FOB testing for identifying Bell's Stage II or III necrotizing enterocolitis (NEC).
• To assess FOB testing in very low birth weight (VLBW) infants.

Main Methods:

• Retrospective review of medical records for VLBW infants (2012-2013).
• Analysis of FOB results in relation to NEC diagnosis and clinical risk factors.
• Logistic regression used to identify predictors of NEC and positive FOB results.

Main Results:

• The incidence of NEC was 3.9% (8/203 infants).
• No NEC cases had positive FOB within 48 hours of diagnosis; only 12.5% within 7 days.
• Sensitivity, specificity, and positive predictive value of FOB for NEC were 0%, 34.4%, and 0%, respectively. Positive FOB was common (67%) but not a significant NEC predictor.

Conclusions:

• Routine FOB testing demonstrated very poor sensitivity, specificity, and predictive value for NEC in VLBW infants.
• Positive FOB results were frequent in VLBW infants, particularly those who were preterm or had intrauterine growth restriction (IUGR).
• FOB testing offers no significant advantage for the early diagnosis of NEC in this population.